Premarket: Pfizer FDA approval increases these stocks

But the scale of the pandemic is generating tons of revenue. In a note released Monday, Morningstar analyst Karen Andersen said she sees sales of the Pfizer shot as reaching $ 35 billion in 2021 and $ 39 billion in 2022. After that, she expects $ 2 billion. dollars in annual sales as the most vulnerable continue to be shot.

FDA approval could further increase demand, although Andersen believes existing contracts will cover any interest increases.

“[The FDA] has now reviewed the six-month safety data of thousands of patients in the phase 3 trial, “Andersen wrote.” This could encourage some people who were uncertain about the long-term safety of the vaccine to be vaccinated. “

“We also hope that this approval will give more influence to public and private organizations that want to demand vaccination, including universities and hospitals,” Andersen wrote.

Take a look at this space: Pfizer and BioNTech aren’t the only stocks benefiting from vaccination campaigns that could safeguard the economic recovery. Investors are also accumulating in travel stocks and movie theaters following FDA news.

Store closures are expected to reach a five-year low

Store closures in the U.S. are expected to drop to a five-year low in 2021, but that’s not exactly good news, according to my CNN Business colleague Nathaniel Meyersohn.

One factor: the industry, which has been hit in recent years by the shift to online shopping, experienced a huge elimination last year, when closures were the highest recorded.

Retailers in the United States are announcing about 3,700 store closures this year, the lowest annual figure since 2016, according to data and commercial real estate data firm CoStar Group, which makes a tracking public announcements of retail chains. The closures are estimated to account for about 40 million square feet of space, the lowest since CoStar began controlling in 2008.

Last year, 12,200 stores closed, as the pandemic forced consumers to limit their visits.

Now, as the economic recovery recovers, the outlook is a little brighter, at least for companies that have weathered the storm.

Only ten large retail companies have filed for bankruptcy this year, compared to nearly 70 last year and 25 to 35 in the previous four years, Moody’s said in a recent investigation report.

“There’s less pressure to close,” said Ken Fenyo, president of retail research and consulting firm Coresight Research. “You’re seeing a strong return to the store. People are spending and it’s starting to come out again.”

Why JD.com shares have risen 15%

Shares of the Chinese e-commerce company rose 15% in Hong Kong on Tuesday after the company exceeded investor expectations for its most recent quarter. JD.com said it added more than 32 million new users during the period, the all-time high.

That’s not all: the company’s shares also benefit from the Cathie Wood effect. Wood’s Ark Investment Management, which is closely monitored by the Robinhood crowd, revealed it had bought shares. Wood had previously warned of a “resumption of valuation” of Chinese technology stocks.

It’s worth nothing: the gains haven’t erased big losses this year. Shares of JD.com continue to fall 18% in 2021, while shares in Alibaba are up 28%. But in the wake of sharp declines last week, when China passed new rules on the collection and use of personal data and proposed major changes to curb the anti-competitive behavior of large Internet companies, the rebound indicates that some investors see good deals.

JD.com, for its part, assured its investors that the tougher regulatory regime would not hurt their prospects.

“We believe the regulatory goals are conducive to JD’s long-term business growth,” Lei Xu, the company’s head of marketing, told analysts after the earnings report. “To date, our business has maintained steady growth and is committed to best compliance practices.”

Until next time

Also today: New home sales in the U.S. for July release at 10 a.m. ET.